找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Human Tumour Xenografts in Anticancer Drug Development; Benjamin Winograd,Michael Peckham,Herbert Michael Conference proceedings 1988 Spr

[復(fù)制鏈接]
樓主: 浮淺
41#
發(fā)表于 2025-3-28 14:41:01 | 只看該作者
Screening of Analogs in Human Ovarian Cancer Xenograftshylmelamine at maximum tolerated doses. As for cisplatin analogs tested in two lines, carboplatin was shown to be similar in efficacy to cisplatin, followed by iproplatin, JM-40 and TN0-38; tetraplatin and spiroplatin were considered less active. Experimental data correlated well with clinical findi
42#
發(fā)表于 2025-3-28 20:16:15 | 只看該作者
43#
發(fā)表于 2025-3-28 23:27:13 | 只看該作者
Activity of Six New Drugs in Head and Neck Cancer Xenograftsmum tolerated doses. 5-Aza-2′-deoxycytidine (5-aza-dCyd), a nucleoside analogue, was active in 1 , moderately active in another and inactive in 3 tu mour lines. Activity was dose-schedule dependent, indicating that new drugs ought to be tested in at least 2 dose-schedules. Trimetrexate, a new folate
44#
發(fā)表于 2025-3-29 06:13:34 | 只看該作者
https://doi.org/10.1007/978-3-642-73252-2Antigen; biochemistry; carcinoma; interferon; transplantation
45#
發(fā)表于 2025-3-29 10:41:56 | 只看該作者
ESO Monographshttp://image.papertrans.cn/h/image/429563.jpg
46#
發(fā)表于 2025-3-29 12:08:02 | 只看該作者
47#
發(fā)表于 2025-3-29 16:39:36 | 只看該作者
48#
發(fā)表于 2025-3-29 23:34:29 | 只看該作者
Bioinformatics - A Student‘s Companiont home and in school. Hypothalamic impairments complicate day-to-day life—high pain tolerance, temperature dysregulation, sleepiness, and constant drive to eat. Pituitary deficiencies of growth hormone and GnRH require skilled endocrine care throughout the lifespan. Children with PWS are at risk for
49#
發(fā)表于 2025-3-30 01:55:30 | 只看該作者
Bingcheng Wang,Chang Jingdentification, creation, and initial classification of reusable application patterns while retrieval, adaptation, and storage reuse tasks with case-based reasoning support are treated briefly at the conclusion as an introductory information about launching research.
50#
發(fā)表于 2025-3-30 05:43:25 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 13:42
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
平凉市| 雷州市| 鱼台县| 禄劝| 武川县| 鹤庆县| 漳浦县| 南溪县| 松滋市| 鹤峰县| 新化县| 涟源市| 乌兰察布市| 松潘县| 丹棱县| 滁州市| 广东省| 潜山县| 志丹县| 五河县| 富锦市| 伊吾县| 海宁市| 运城市| 紫金县| 尼勒克县| 宁国市| 德化县| 大荔县| 苗栗市| 巩义市| 普兰县| 达拉特旗| 南乐县| 理塘县| 南川市| 诸暨市| 潞城市| 长宁县| 米脂县| 临城县|